Abstract
In this chapter, we describe how our bright little daughter, Laura, was cut off from the world by an “autistic regression”; how she has fared since; and our experience treating her.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Endnotes
World Health Organization, International Classification of Diseases, 10th ed., Geneva, 1992: pp. 256–257.
Rimland, B., “Long-term follow-up: Early intervention effects lasting,” in Autism Research Review International, Vol. 7, No. 1, 1993: pp. 1, 6.
McEachin, J. J., Smith, T., and Lovaas, O. I., “Long-term outcome for children with autism who received early intensive behavioral treatment,” in American Journal on Mental Retardation, Vol. 97, No. 4, 1993: pp. 359–372.
Lovaas, O. I., Ackerman, A. B., Alexander, D., Firestone, P., Perkins, J., and Young, D., Teaching Developmentally Disabled Children: The “Me” Book, Pro-Ed, Austin, TX, 1981.
O’Reilly, B. A., and Waring, R., “Enzyme and sulfur oxidation deficiencies in autistic children with known food/chemical intolerances,” in Journal of Orthomolecular Medicine Vol. 8, No. 4, December 1993: pp. 198–200.
Gillberg, C., and Coleman, M., The Biology of the Autistic Syndromes, 2nd ed., Mackeith Press, London, 1992.
Rimland, B., “Studies of high dosage vitamin B6 in autistic children and adults—1965–1994,” The Autism Research Institute, San Diego, 1994.
Goldenberg, C., Information package on gammaglobulin therapy available from the Autism Research Institute, San Diego (referred to in Autism Research Review International, Vol. 9, No. 2, 1995: p. 7).
Stefanatos, G.A., Grover, W., and Geller, E., “Case study: Corticosteroid treatment of language regression in pervasive developmental disorder,” in Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 34, No. 8, August 1995: pp. 1107–1111.
Warren, R.P., Singh, V.K., Cole, P., Odell, J.D., Pingree, C.B., Warren, W.L., DeWitt, C.W., and McCullough, M., “Possible association of the extended MHC haplotype B44-SC30-DR4 with autism,” in Immunogenetics, Vol. 36, 1992: pp. 203–207.
Daniels, W.W., Warren, R.P., Odell, J.D., Maciulis, A., Burger, R.A., Warren, W. L., and Torres, A. R., “Increased frequency of the extended or ancestral haplotype B44-SC30-DR4 in autism,” in Neuropsychobiology, Vol. 32, No. 3, 1995: pp. 120–123.
Baker, S.M., and Pangborn, J., “Clinical Assessment Options for Children with Autism and Related Disorders” (the “Defeat Autism Now!” manual), Autism Research Institute, San Diego, 1996.
Baker and Pangborn.
Tsaltas, M.O., “A pilot study on allergic responses,” in Journal of Autism and Developmental Disorders, Vol. 16, 1986: pp. 91–92.
Dorfman, K., Lemer, P., and Nadeler, J., “What puts a child at risk for developmental delays?—Results of the Developmental Delay Registry survey”: available from the Developmental Delay Registry, 6701 Fairfax Road, Chevy Chase, MD 20815.
Laxer, G., Rey, M., and Ritvo, E.R., “Brief report: A comparison of potentially pathologic factors in European children with autism, Down’s syndrome, and multiple physical handicaps,” in Journal of Autism and Developmental Disorders, Vol. 18, No. 2, 1988: pp. 309–313.
Rimland, B., “Is there an autism epidemic?” in Autism Research Review International, Vol. 9, No. 3, 1995: p. 3.
Lovaas, O.I., “Behavioral treatment and normal educational and intellectual functioning in young autistic children,” in Journal of Consulting and Clinical Psychology, Vol. 55, No. 1, 1987: pp: 3–9.
Baron-Cohen, S., Allen, J., and Gillberg, C., “Can autism be detected at 18 months? The needle, the haystack and the CHAT,” in British Journal of Psychiatry, Vol. 161, 1992: pp. 839–843.
Stubbs, E.G., Crawford, M.L., Burder, D.R., and Vandenbark, A.A., “Depressed lymphocyte responsiveness in autistic children,” in Journal of Autism and Childhood Schizophrenia, Vol. 7, 1977: pp. 49–55.
Warren, R.P., Margaretten, N.C., Pace, N.C., and Foster, A., “Immune abnormalities in patients with autism,” in Journal of Autism and Developmental Disorders, Vol. 16, 1986: pp. 189–197.
Warren, R.P., Foster, A., and Margaretten, N.C., “Reduced natural killer cell activity in autism,” in Journal of American Child and Adolescent Psychiatry, Vol. 26, 1987: pp. 333–335.
Warren, R.P., Oink, L.J., Burger, R.A., and others, “Deficiency of suppressor inducer (CD4 + CD45RA +) T cells in autism,” in Immunological Investigations, Vol. 19, 1990: pp. 245–251.
Warren, R.P., Singh, V.K., Cole, P., Odell, J., Pingree, C.B., Warren, W.L., and White, E., “Increased frequency of the null allele at the complement C4B locus in autism,” in Clinical and Experimental Immunology, Vol. 83, 1991: pp. 438–440.
Bettison, S., “Abnormal responses to sound and the long-term effects of a new treatment program,” in Building Bridges: Proceedings of the 1995 National Autism Conference (Australia), Autistic Children’s Association of Queensland (Inc.), Brisbane, 1995: pp. 25–40.
Editor information
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sue, Ferris, S. (1998). Laura’s Story. In: Catalano, R.A. (eds) When Autism Strikes. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-5964-5_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-5964-5_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45789-0
Online ISBN: 978-1-4899-5964-5
eBook Packages: Springer Book Archive